CCB delivered disappointing 1Q25 results as net profit declined 4.0%, dragged by NIM compression and tepid fee income. Furthermore, revenue growth was no longer supported by trading gains, as yields rebounded during 1Q25. Asset quality was a silver lining as CCB highlighted the sequential improvement in the retail and property developer segments. Management also noted that tariff risk is manageable in terms of both fee income and asset quality. Downgrade to HOLD. Target price: HK$7.00.
KEY HIGHLIGHTS Results China Construction Bank (939 HK/HOLD/HK$6.79/Target: HK$7.00) CCB delivered disappointing 1Q25 results as net profit declined 4.0%, dragged by NIM compression and tepid fee income. Furthermore, revenue growth was no longer supported by trading gains, as yields rebounded during 1Q25. Asset quality was a silver lining as CCB highlighted the sequential improvement in the retail and property developer segments. Management also noted that tariff risk is manageable in terms of...
Trump’s unprecedented reciprocal tariffs triggered a massive sell-off in the Hong Kong market. On 30 Mar 25, China’s four SOE banks also announced their capital-raising plans, with the dilution impact largely in line with our expectations. We believe the potential risks from Trump's tariffs are manageable for Chinese banks. Hence, investors may shift back to defensive, high dividend yield names like Chinese banks amid the sentiment hit from the tariff shocks. Upgrade to OVERWEIGHT. Top pick: CCB...
GREATER CHINA Sector Banking Playing safe amid tariff fears. Small/Mid Cap Highlights JBM Healthcare (2161 HK/BUY/HK$1.75/Target: HK$2.42) FY26: New rounds of marketing campaigns to fuel growth. INDONESIA Results Merdeka Copper Gold (MDKA IJ/BUY/Rp1,040/Target: Rp1,900) FY24: Below our and street’s expectations MALAYSIA Sector Gloves ...
CCB’s 2024 earnings (+0.9% yoy) were above our expectation, mainly driven by its resilient NIM on better deposit cost management, strong trading gains and lower impairment. Asset quality remains solid but pressure on the retail segment is increasing. MoF will inject Rmb105b of new capital into CCB which will result in a 4.3% equity dilution and 50bp boost in CET1 ratio. We expect a largely neutral market reaction due to a smaller dilution size. Maintain BUY. Target price: HK$7.50.
KEY HIGHLIGHTS Results China Construction Bank (939 HK/BUY/HK$6.70/Target: HK$7.50) CCB’s 2024 earnings (+0.9% yoy) were above our expectation, mainly driven by its resilient NIM on better deposit cost management, strong trading gains and lower impairment. Asset quality remains solid but pressure on the retail segment is increasing. MoF will inject Rmb105b of new capital into CCB which will result in a 4.3% equity dilution and 50bp boost in CET1 ratio. We expect a largely neutral market reacti...
GREATER CHINA Results China Construction Bank (939 HK/BUY/HK$6.70/Target: HK$7.50): 2024: Above expectations on better NIM; recapitalisation plan is finalised. China Shineway Pharmaceutical (2877 HK/HOLD/HK$8.05/Target: HK$8.50): 2024: Bottom line misses; targets revenue growth of 10% yoy in 2025. Great Wall Motor (2333 HK/BUY/HK$14.20/Target: HK$23.00): 4Q24: Earnings in line with estimates. Maintain BUY. Target price: HK$23.00. Haier Smart Home (6690 HK/BUY/HK$24.70/Target: HK$37.80): 2024: 4Q...
China banks reported improved earnings growth, driven by narrower revenue declines, strong trading gains and lower credit costs. We expect the sequential NIM decline to worsen in 4Q24 due to policy rate cuts. However, we believe China banks will maintain positive earnings growth for 2024, supported by the low base effect in 4Q23 and the stimulus package announced in late-Sep 24. Maintain MARKET WEIGHT. Top pick: CMB.
CCB’s 3Q24 results beat our expectations with a turnaround in profit growth, thanks to lower provisions and a 4.4x increase in other NII. Revenue dropped 2.7% yoy due to NIM compression and tepid fee income. CCB highlighted that the existing headwinds will weigh on its NIM in 2025 but the recent rate cuts will be neutral to its NIM movement in the long run. We believe the restored earnings growth could ease investor concerns about the sustainability of CCB’s high dividend yield. Maintain BUY. Ta...
KEY HIGHLIGHTS Results ASMPT (522 HK/BUY/HK$87.00/Target: HK$104.50) ASMPT’s Semi solution business registered better-than-expected revenue and margins in 3Q24 thanks to robust advanced packaging demand, which led to a 10% beat vs our operating profit estimates, although reported net profit ended up below expectations due to forex loss. ASMPT will remain a key beneficiary of the AI investment trend, and we recommend accumulating after its recent share price correction. Maintain BUY. Target p...
GREATER CHINA Results ASMPT (522 HK/BUY/HK$87.00/Target: HK$104.50): 3Q24: Reported earnings miss expectations on forex loss but core business recovery picking up; maintain BUY. BYD Company (1211 HK/HOLD/HK$295.00/Target: HK$260.00): 3Q24: Earnings up 12% yoy, in line with estimates. Maintain HOLD. China Construction Bank (939 HK/BUY/HK$5.97/Target: HK$6.70): 3Q24: Earnings growth returns to positive territory on lower credit cost. Foxconn Industrial Internet (601138 CH/BUY/Rmb24.84/Target: Rmb...
On 12 Oct 24, the MOF updated its countercyclical supportive policies and structural reforms to achieve high quality growth. The key positives are initiatives to resolve local government debt and substantially increase the debt limit. Finer details of the policies are lacking due to pending approval by the Standing Committee of the NPC. Overall, these are positive but we downgrade the banking sector to MARKET WEIGHT due to the potential EPS and ROE dilution on SOE banks from the capital injectio...
China banks reported a smaller earnings decline in 2Q24 on lower impairment charges and strong trading income. We estimate that the 80bp mortgage repricing could hit banks’ earnings by 6.5bp and 9.2% in 2025. The fundamental weakness due to macro headwinds and mortgage repricing news could weigh on share prices. Nonetheless, the depressed valuations and resurging dividend yields after the recent correction could be a silver lining again for defensive plays. Maintain OVERWEIGHT. Top pick: CMB.
CCB’s 2Q24 earnings (-1.4% yoy) were slightly below our expectation. PPOP decreased 4.7% yoy due to larger NIM dilution and fee income decline, partly offset by strong trading income. Despite that, management guided that the deposit rate cut in July could fully offset the impact of LPR cuts, and NIM downward pressure will continue to ease in 2H24. Asset quality remains decent with flattish NPL ratio but pressure on the retail segment is increasing. Maintain BUY. Target price: HK$6.00.
KEY HIGHLIGHTS Results China Construction Bank (939 HK/BUY/HK$5.43/Target: HK$6.00) CCB’s 2Q24 earnings (-1.4% yoy) were slightly below our expectation. PPOP decreased 4.7% yoy due to larger NIM dilution and fee income decline, partly offset by strong trading income. Despite that, management guided that the deposit rate cut in July could fully offset the impact of LPR cuts, and NIM downward pressure will continue to ease in 2H24. Asset quality remains decent with flattish NPL ratio but press...
GREATER CHINA Results China Construction Bank (939 HK/BUY/HK$5.43/Target: HK$6.00): 2Q24: Earnings decline narrowed to 1.4% on strong trading income. China Merchants Bank. (3968 HK/BUY/HK$32.35/Target: HK$42.00): 1H24: Still waiting to thrive. China Tourism Group Duty Free (601888 CH/BUY/Rmb58.93/Target: Rmb83.40): 2Q24: Slight earnings miss; Hainan duty-free business under pressure; airport business recovery underway. Kingmed Diagnostics (603882 CH/BUY/Rmb25.66/Target: Rmb35.00): 1H24: Signific...
The PBOC reiterated it will reduce its focus on quantitative targets and elevate the importance of interest rates in its quarterly report. According to NAFR, Chinese banks delivered a muted earnings growth in 2Q24 due to a slowdown in balance sheet growth, but NIM and asset quality pressures are easing. Upside surprise could come from noninterest income due to a bullish bond market. Maintain OVERWEIGHT. Top pick: CMB.
The PBOC plans to sell CGBs to cool the overheated bond market, and we estimate the central bank may borrow up to Rmb3.8t of CGBs for this move. While this could lead to unrealised losses on banks' FVTPL bond positions, it might also prompt banks to realise gains on FVTPL and FVTOCI bond investments which will drive their trading income. Additionally, a stabilised bond yield environment could support banks’ asset yield and NIM performance. Maintain OVERWEIGHT. Top pick: CMB.
The impact of the recent property rescue package is mixed. Asset quality concern is expected to ease but the lower mortgage rate could continue to weigh on banks’ NIM. Thus, further policy supports from the PBOC, such as RRR and deposit rate cuts, are much needed. Meanwhile, the potential removal of dividend tax for Southbound investors could boost the sector’s valuation further given the attractive A/H spreads and high dividend yields. Upgrade to MARKET WEIGHT. Top pick: CMB.
CCB reported in-line results with a 2.2% yoy net profit decline. PPOP reduced by 3.4% yoy due to muted fee income and higher CIR. NIM narrowed by 2bp qoq to 1.57%, dragged by declining loan yields but offset by better liability management which resulted in a 7bp lower deposit funding cost. NPL ratio improved on a higher write-off but the gross NPL formation ratio edged up. Tier-1 capital ratio was boosted 96bp qoq to 14.11% under the New Capital Rule. Maintain BUY. Target price: HK$6.00.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.